Effects of intraperitoneal chemotherapy with mitomycin C on the prevention of peritoneal recurrence in colorectal cancer patients with positive peritoneal lavage cytology findings

Annals of Surgical Oncology

Volumn 18, Issue 2, 2011, Pages 396-404

  Noura, Shingo ^a   Ohue, Masayuki ^a   Shingai, Tatsushi ^a   Kano, Shingo ^a   Ohigashi, Hiroaki ^a   Yano, Masahiko ^a   Ishikawa, Osamu ^a   Takenaka, Akemi ^a   Murata, Kohei ^b   Kameyama, Masao ^c  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b Suita Municipal Hospital   (Japan)

^c Bell Land General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; MITOMYCIN C;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; COLORECTAL CANCER; CYTOLOGY; DISEASE FREE SURVIVAL; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERITONEUM CANCER; PERITONEUM LAVAGE;

ANTIBIOTICS, ANTINEOPLASTIC; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAPERITONEAL; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PERITONEAL LAVAGE; PERITONEAL NEOPLASMS; PERITONEUM; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79951549875     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1319-2     Document Type: Article

References (39)

1. I Cohn Jr 1967 Implantation in cancer of the colon Surg Gynecol Obstet. 124 501 508
2. H Kobayashi H Mochizuki K Sugihara T Morita K Kotake T Teramoto, et al. 2007 Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study Surgery. 141 67 75 10.1016/j.surg.2006.07.020 (Pubitemid 44918081)
3. T Kato K Yasui T Hirai Y Kanemitsu T Mori K Sugihara, et al. 2003 Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions Dis Colon Rectum. 46 S22 S31
4. M Higashiyama K Kodama N Higaki K Takami K Murata M Kameyama, et al. 2003 Surgery for pulmonary metastases from colorectal cancer: the importance of prethoracotomy serum carcinoembryonic antigen as an indicator of prognosis Jpn J Thorac Cardiovasc Surg. 51 289 296 10.1007/BF02719380 (Pubitemid 38166264)
5. OA Ogunbiyi K McKenna EH Birnbaum JW Fleshman IJ Kodner 1997 Aggressive surgical management of recurrent rectal cancer-is it worthwhile? Dis Colon Rectum. 40 150 155 1:STN:280:DyaK2s3jtVWksg%3D%3D 10.1007/BF02054979 (Pubitemid 27074283)
6. K Tanaka S Noura M Ohue Y Seki T Yamada I Miyashiro, et al. 2008 Doubling time of carcinoembryonic antigen is a significant prognostic factor after the surgical resection of locally recurrent rectal cancer Dig Surg. 25 319 324 1:CAS:528:DC%2BD1cXht1Grs7rM 10.1159/000158597
7. S Sadahiro T Suzuki K Ishikawa T Nakamura Y Tanaka T Masuda, et al. 2003 Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years Hepatogastroenterology. 50 1362 1366 (Pubitemid 37186484)
8. K Hase H Ueno N Kuranaga K Utsunomiya S Kanabe H Mochizuki 1998 Intraperitoneal exfoliated cancer cells in patients with colorectal cancer Dis Colon Rectum. 41 1134 1140 1:STN:280:DyaK1cvhvF2htA%3D%3D 10.1007/BF02239435 (Pubitemid 28432454)
9. S Yamamoto T Akasu S Fujita Y Moriya 2003 Long-term prognostic value of conventional peritoneal cytology after curative resection for colorectal carcinoma Jpn J Clin Oncol. 33 33 37 10.1093/jjco/hyg007 (Pubitemid 43102878)
10. S Baskaranathan J Philips P McCredden MJ Solomon 2004 Free colorectal cancer cells on the peritoneal surface: correlation with pathologic variables and survival Dis Colon Rectum. 47 2076 2079 10.1007/s10350-004-0723-8 (Pubitemid 40179068)
11. S Rekhraj O Aziz S Prabhudesai E Zacharakis F Mohr T Athanasiou, et al. 2008 Can intra-operative intraperitoneal free cancer cell detection techniques identify patients at higher recurrence risk following curative colorectal cancer resection: a meta-analysis Ann Surg Oncol. 15 60 68 10.1245/s10434-007-9591-5
12. S Noura M Ohue Y Seki M Yano O Ishikawa M Kameyama 2009 Long-term prognostic value of conventional peritoneal lavage cytology in patients undergoing curative colorectal cancer resection Dis Colon Rectum. 52 1312 1320
13. A Yamaguchi Y Tsukioka S Fushida Y Kurosaka M Kanno Y Yonemura, et al. 1992 Intraperitoneal hyperthermic treatment for peritoneal dissemination of colorectal cancers Dis Colon Rectum. 35 964 968 1:STN:280:DyaK3s%2FhtVWksw%3D%3D 10.1007/BF02253499
14. DE Brenner 1986 Intraperitoneal chemotherapy: a review J Clin Oncol. 4 1135 1147 1:STN:280:DyaL283ltleguw%3D%3D (Pubitemid 16059741)
15. S Koga R Hamazoe M Maeta N Shimizu A Murakami T Wakatsuki 1988 Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C Cancer. 61 232 237 1:STN:280:DyaL1c%2FnvFyrsQ%3D%3D 10.1002/1097-0142(19880115)61:2<232::AID- CNCR2820610205>3.0.CO;2-U (Pubitemid 18056474)
16. R Hamazoe M Maeta N Kaibara 1994 Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study Cancer 73 2048 2052 1:STN:280:DyaK2c3gsl2lsw%3D%3D 10.1002/1097-0142(19940415)73:8<2048::AID-CNCR2820730806>3.0.CO;2-Q (Pubitemid 24107956)
17. W Yu I Whang I Suh A Averbach D Chang PH Sugarbaker 1998 Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer Ann Surg. 228 347 354 1:STN:280: DyaK1cvhtlynuw%3D%3D 10.1097/00000658-199809000-00007 (Pubitemid 30191697)
18. PH Sugarbaker FJ Gianola JC Speyer R Wesley I Barofsky CE Meyers 1985 Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer Surgery. 98 414 422 1:STN:280:DyaL2MzgtFSgug%3D%3D (Pubitemid 16143766)
19. K Hojo 1989 Surgery for far-advanced colorectal cancer-extension of surgical indication and its results Nippon Geka Gakkai Zasshi. 90 1428 1431 1:STN:280:DyaK3c%2Fms1arsA%3D%3D
20. M Kameyama I Fukuda S Imaoka S Masutani H Ohigashi Y Sasaki, et al. 1991 Prevention of peritoneal dissemination after colorectal surgery-significance of MMC administration in abdominal cavity Gan To Kagaku Ryoho. 18 1808 1811 1:STN:280:DyaK3MzksFentA%3D%3D
21. Sobin LH, Wittekind Ch. TNM Classification of Malignant Tumours. 6th ed. New York: Wiley-Liss; 2002.
22. O Glehen F Kwiatkowski PH Sugarbaker D Elias EA Levine M De Simone, et al. 2004 Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study J Clin Oncol. 22 3284 3292 1:STN:280:DC%2BD2cvgs1Giuw%3D%3D 10.1200/JCO.2004.10.012 (Pubitemid 41103684)
23. TD Yan D Black R Savady PH Sugarbaker 2006 Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma J Clin Oncol. 24 4011 4019 10.1200/JCO.2006.07.1142 (Pubitemid 46630752)
24. VJ Verwaal S Bruin H Boot G van Slooten H van Tinteren 2008 8-Year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer Ann Surg Oncol. 15 2426 2432 10.1245/s10434-008-9966-2
25. TD Yan DL Morris 2008 Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care? Ann Surg. 248 829 835
26. D Elias JH Lefevre J Chevalier A Brouquet F Marchal JM Classe, et al. 2009 Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin J Clin Oncol. 27 681 685 10.1200/JCO.2008.19.7160
27. D Elias F Gilly F Boutitie F Quenet JM Bereder B Mansvelt, et al. 2010 Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study J Clin Oncol. 28 63 68 10.1200/JCO.2009.23.9285
28. RM Smeenk VJ Verwaal FA Zoetmulder 2007 Learning curve of combined modality treatment in peritoneal surface disease Br J Surg. 94 1408 1414 1:CAS:528:DC%2BD2sXhsVGitbbO 10.1002/bjs.5863 (Pubitemid 350144391)
29. Levine EA, Stewart JH IV, Russell GB, Geisinger KR, Loggie BL, Shen P. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures. J Am Coll Surg. 2007;204:943-53; discussion 953-5. (Pubitemid 46661217)
30. K Hillan B Nordlinger F Ballet JP Puts R Infante 1988 The healing of colonic anastomoses after early intraperitoneal chemotherapy: an experimental study in rats J Surg Res. 44 166 171 1:CAS:528:DyaL1cXhsVejsrc%3D 10.1016/0022-4804(88)90045-5 (Pubitemid 18064229)
31. JK Martin Jr JR Goellner 1986 Abdominal fluid cytology in patients with gastrointestinal malignant lesions Mayo Clin Proc. 61 467 471 (Pubitemid 16100861)
32. P Wind B Norklinger V Roger A Kahlil E Guin R Parc 1999 Long-term prognostic value of positive peritoneal washing in colon cancer Scand J Gastroenterol. 34 606 610 1:STN:280:DyaK1MzmslahsQ%3D%3D 10.1080/ 003655299750026074 (Pubitemid 29339215)
33. P Vogel J Ruschoff S Kummel H Zirngibl F Hofstadter W Hohenberger, et al. 2000 Prognostic value of microscopic peritoneal dissemination: comparison between colon and gastric cancer Dis Colon Rectum. 43 92 100 1:STN:280:DC%2BD3c3ntFagug%3D%3D 10.1007/BF02237250 (Pubitemid 30056669)
34. B Bosch U Guller A Schnider R Maurer F Harder U Metzger, et al. 2003 Perioperative detection of disseminated tumour cells is an independent prognostic factor in patients with colorectal cancer Br J Surg. 90 882 888 1:STN:280:DC%2BD3szitlGqtQ%3D%3D 10.1002/bjs.4129 (Pubitemid 36886394)
35. U Guller P Zajac A Schnider B Bosch S Vorburger M Zuber, et al. 2002 Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer Ann Surg. 236 768 775 10.1097/00000658-200212000-00009 discussion 775-6 (Pubitemid 35403232)
36. JM Lloyd CM McIver SA Stephenson PJ Hewett N Rieger JE Hardingham 2006 Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells Clin Cancer Res. 12 417 423 1:CAS:528:DC%2BD28XmtlKjtQ%3D%3D 10.1158/1078-0432.CCR-05-1473 (Pubitemid 43166130)
37. M Hara H Nakanishi Q Jun Y Kanemitsu S Ito Y Mochizuki, et al. 2007 Comparative analysis of intraperitoneal minimal free cancer cells between colorectal and gastric cancer patients using quantitative RT-PCR: possible reason for rare peritoneal recurrence in colorectal cancer Clin Exp Metastasis. 24 179 189 10.1007/s10585-007-9067-9 (Pubitemid 46850229)
38. A Schott I Vogel U Krueger H Kalthoff HW Schreiber W Schmiegel, et al. 1998 Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker Ann Surg. 227 372 379 1:STN:280:DyaK1c7os1aruw%3D%3D 10.1097/00000658-199803000- 00009 (Pubitemid 28131018)
39. MS Cohen MF Al-Kasspooles SK Williamson D Henry M Broward KF Roby 2010 Combination intraperitoneal chemotherapy is superior to mitomycin C or oxaliplatin for colorectal carcinomatosis in vivo Ann Surg Oncol. 17 296 303 10.1245/s10434-009-0669-0